Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1996 1
2000 2
2002 2
2003 3
2004 3
2005 1
2006 7
2007 1
2008 4
2009 8
2010 4
2011 7
2012 13
2013 10
2014 5
2015 12
2016 11
2017 21
2018 19
2019 20
2020 17
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 24309088

151 results
Results by year
Filters applied: . Clear all
Page 1
Cannabidiol as a potential treatment for psychosis.
Schubart CD, Sommer IE, Fusar-Poli P, de Witte L, Kahn RS, Boks MP. Schubart CD, et al. Eur Neuropsychopharmacol. 2014 Jan;24(1):51-64. doi: 10.1016/j.euroneuro.2013.11.002. Epub 2013 Nov 15. Eur Neuropsychopharmacol. 2014. PMID: 24309088 Review.
Could cannabidiol be used as an alternative to antipsychotics?
Fakhoury M. Fakhoury M. J Psychiatr Res. 2016 Sep;80:14-21. doi: 10.1016/j.jpsychires.2016.05.013. Epub 2016 May 28. J Psychiatr Res. 2016. PMID: 27267317 Review.
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.
Zuardi AW, Crippa JA, Hallak JE, Moreira FA, Guimarães FS. Zuardi AW, et al. Braz J Med Biol Res. 2006 Apr;39(4):421-9. doi: 10.1590/s0100-879x2006000400001. Epub 2006 Apr 3. Braz J Med Biol Res. 2006. PMID: 16612464 Free article. Review.
Cannabinoids and Schizophrenia: Risks and Therapeutic Potential.
Manseau MW, Goff DC. Manseau MW, et al. Neurotherapeutics. 2015 Oct;12(4):816-24. doi: 10.1007/s13311-015-0382-6. Neurotherapeutics. 2015. PMID: 26311150 Free PMC article. Review.
Cannabidiol for the treatment of psychosis in Parkinson's disease.
Zuardi AW, Crippa JA, Hallak JE, Pinto JP, Chagas MH, Rodrigues GG, Dursun SM, Tumas V. Zuardi AW, et al. J Psychopharmacol. 2009 Nov;23(8):979-83. doi: 10.1177/0269881108096519. Epub 2008 Sep 18. J Psychopharmacol. 2009. PMID: 18801821
151 results
Jump to page
Feedback